Home - Products - Angiogenesis - EGFR - Cavutilide

Cavutilide

CAS No. 1276186-19-6

Cavutilide( —— )

Catalog No. M35602 CAS No. 1276186-19-6

Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	686	In Stock
10MG	938	In Stock
25MG	1444	In Stock
50MG	1841	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Cavutilide
Note

Research use only, not for human use.
Brief Description

Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.
Description

Cavutilide, benzamide, is used as an antiarrhythmic, antiarythmique.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

EGFR
Recptor

EGFR
Research Area

——
Indication

——

Chemical Information

CAS Number

1276186-19-6
Formula Weight

399.458
Molecular Formula

C22H26FN3O3
Purity

>98% (HPLC)
Solubility

——
SMILES

CCN1CCC(CC(c(cc2)ccc2F)NC(c(cc2)ccc2[N+]([O-])=O)=O)CC1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. WHO Drug Information, Vol. 36, No. 2, 2022.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

PD 089828

PD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 μM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 = 0.18 μM)
AG-1557 hydrochlorid...

AG-1557 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
Cephalotaxine

Cephalotaxine is an antiviral and an antitumor agent.

Sign In Join Free